Do you want to stay up to date with the latest BHD news? This is the place to be!
Here we will let you know about the latest BHD research, events, and opportunities to get involved with our work.
In people with BHD, smoking is not thought to impact lung cyst formation or lung function. However, it is not clear whether smoking and COPD affect FLCN function, the gene that is mutated in BHD.
On average it takes 5 years for a rare disease to be diagnosed. A recent study from Germany also suggests gender may play a role in how quickly someone is diagnosed with BHD.
Kidney cancer is the 6th most common cancer in the developed world. Many genetic conditions are linked with kidney cancer including BHD.
Birt-Hogg-Dubé syndrome is associated with an increased risk of kidney cancer. It is important to understand how kidney cancer can develop so we can know how to best treat it.
Recently several papers have been published about kidney cancer that are relevant to Birt-Hogg-Dubé syndrome. In this blog, we summarise the papers and share what we can learn from them.
A study looked at different inherited kidney cancers includeing BHD at a single cell level. This means looking at the individual cells that make up the cancer.
A new study has been published looking at the prevalence of BHD among people who have a collapsed lung for no apparent reason.
Tuberous sclerosis complex is a rare inherited condition. It shares some features with BHD. Here, we compare Tuberous sclerosis complex and BHD.
The first study of BHD in China was published in 2008. However, by the end of 2021 there were only 221 Chinese patients reported. In 2019, a Rare Lung Disease Clinic was set up at The First Affiliated Hospital of USCT in Anhui province, China.
The prevalence of Birt-Hogg-Dubé syndrome is currently unknown. Some reports have estimated the prevalence to be 1 in 200,000 people, but this is likely an underestimate of the true figure.
Our cells need to be able to sense and respond to our body’s needs. Mechanistic target of rapamycin complex 1 (mTORC1) is a protein in our cells that acts as a central hub for this sensing ability. Why is this relevant to BHD?
At the BHD Foundation, we support individuals with BHD worldwide. Much of the research on BHD has been done in Europe and the US and so we were excited to see the first study of BHD in India.